Need help finding what you are looking for?
Contact Us
PUBLISHER: Lucintel | PRODUCT CODE: 1801388
PUBLISHER: Lucintel | PRODUCT CODE: 1801388
Rabbit Hemorrhagic Disease Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
The future of the global rabbit hemorrhagic disease vaccine market looks promising with opportunities in veterinary use (domestic rabbits), wild rabbit protection, and zoo and wildlife conservation markets. The global rabbit hemorrhagic disease vaccine market is expected to grow with a CAGR of 10.5% from 2025 to 2031. The major drivers for this market are innovative developments, advancements, and cutting-edge technologies.
- Lucintel forecasts that, within the type category, inactivated vaccines are expected to witness the highest growth over the forecast period due to inactivated vaccines dominating the market because of their proven efficacy and safety.
- Within the application category, veterinary use is expected to witness the highest growth due to the growing demand for disease prevention in commercial rabbit farming, which is boosting veterinary vaccine use.
- In terms of region, North America is expected to witness the highest growth over the forecast period.
Emerging Trends in the Rabbit Hemorrhagic Disease Vaccine Market
The rabbit hemorrhagic disease vaccine market has been undergoing some changes buoyed by improvements in technology, awareness of rabbit hemorrhagic disease outbreaks, and the necessity of biosecurity for rabbit farming. Consequently, there are numerous changing patterns dominating the market. These trends demonstrate growing demand and recognition of regions that require a wider use of strategies related to disease prevention. The following are the five important trends that are changing the global rabbit hemorrhagic disease vaccine market.
- Increased interest in rabbit hemorrhagic disease V2 vaccines: A more virulent strain of the virus, rabbit hemorrhagic disease V2, has now caused the need for vaccines that protect against both rabbit hemorrhagic disease V1 and rabbit hemorrhagic disease V2 viruses. Rabbit hemorrhagic disease V2 vaccines have been effective in preventing outbreaks in regions that have in the past never used rabbit hemorrhagic disease V1 vaccines. This trend is changing the vaccine market as producers and governments are moving to multi-strain vaccines, opening up doors for manufacturers.
- Vaccination programs sponsored by the government: Due to the rising instances of rabbit hemorrhagic disease outbreaks, many nations have launched several government-sponsored vaccination programs. These programs are designed to safeguard wild and commercial populations of rabbits and, therefore, the sustainability of rabbit farming enterprises. The government-led effort is also easing the burden on farmers by ensuring more widespread adoption of the vaccines. This trend is going to boost growth in the market even more, especially in areas with a high concentration of rabbit populations such as China and Europe.
- Veterinarians' duty and responsibility: There has been a rise in educational campaigns directed towards rabbit veterinarians and rabbit owners as public awareness of rabbit hemorrhagic disease increases. Veterinarians are actively involved in educating breeders about the need for vaccination and early detection of the disease. As a result, the number of vaccinations given to rabbits in pet and commercial roles has increased. More veterinarians are expected to increase awareness of the rabbit hemorrhagic disease vaccine's market since more people will be made aware of the disease and the vaccines available.
- Enhancement in vaccine efficacy and safety: Apart from the existing rabbit hemorrhagic disease virus, the incidence of rabbit hemorrhagic disease viruses is on the rise, making improvements in vaccine formulations more demanding. Adoption of better vaccine technology is also gaining attention as vaccine manufacturers strive to deliver better immune responses with fewer doses and provide cross-strain immunity. Innovation has 'jump-started' the market to seek higher vaccine technology to limit the number of booster shots needed and reduce the total costs of vaccination for farmers.
- Emerging economies outlast other markets: Economies in Southeast Asia, Latin America, and Africa are experiencing rabbit farming assimilation, resulting in higher demand for the rabbit hemorrhagic disease vaccine. As these emerging markets grow stronger, domestic authorities and international organizations consider investing in biosecurity and animal health, hence promoting vaccines. The development and distribution of the rabbit hemorrhagic disease vaccine could help lower costs, making them more accessible to farmers in these countries. This emerging market offers huge growth potential for vaccine manufacturers.
Both opening and expanding trends in the global rabbit hemorrhagic disease vaccine market have agreed on the pivot towards better and improved vaccine formulations, greater government interventions and responsibilities, as well as a growing awareness among veterinarians and farmers. The market is changing, and the demand for multi-strain vaccines, along with funded initiatives from the government and increased knowledge of veterinary systems, is transforming the market. When developing countries come to the fore economically and vaccine efficacy improves, these patterns are poised to catalyze cross-border expansion of rabbit hemorrhagic disease vaccines and enhance disease management.
Recent Developments in the Rabbit Hemorrhagic Disease Vaccine Market
The rabbit hemorrhagic disease vaccine market has been undergoing change over the last couple of years due to several driving developments. As the disease persists among domestic and wild rabbit populations, more efforts in vaccine development, government policy support, and outreach are essential. Outlined below are five notable trends affecting the market.
- Emergence of rabbit hemorrhagic disease V2 vaccines research and its consequences: The emergence and licensing of a vaccine that protects against both strains-rabbit hemorrhagic disease V1 and V2-has been a major milestone. Clinical studies have demonstrated the existence of a strain that provides greater coverage, especially in areas where rabbit hemorrhagic disease V2 is reported more frequently. This development has helped guarantee more comprehensive protection and has spurred research and development, as multi-strain vaccines remain the industry standard.
- Rabbit hemorrhagic disease vaccination support programs fostered by governments: In Europe, China, and Australia, some governments have allocated funds to catalyze vaccination among farmers. These policies reduce the cost burden on farmers, making vaccination more affordable, which has positively impacted vaccine uptake and disease control, leading to market stability.
- Enhanced funding for vaccines: The rising global demand has led to increased investments in developing better and cheaper vaccine formulations. Research aims to maintain or improve vaccine effectiveness throughout storage, administration, and duration of effects. Such advancements are leading to the development of next-generation vaccines, expanding the future market.
- Increase in vaccine production: Due to the growing global market, more vaccine producers are expanding their capabilities, especially in China and Europe, to meet domestic and international demand. Increased production ensures vaccine availability even in remote or neglected areas, supporting global disease elimination efforts.
- Interoperability between public administration and private business: Public-private partnerships are crucial in making vaccines accessible. These collaborations have developed more effective distribution methods, ensuring vaccines reach both commercial and pet rabbit owners and are well-managed within systems.
Important changes in global trends of the rabbit hemorrhagic disease vaccine market are expected to improve disease control and market growth. Factors such as the introduction of rabbit hemorrhagic disease V2 vaccines, government initiatives, increased research funding, expansion of production, and public-private partnerships will enhance vaccine development and availability, strengthening efforts to control the disease.
Strategic Growth Opportunities in the Rabbit Hemorrhagic Disease Vaccine Market
The need for effective prevention is rising due to the economic impact of the disease. Increased vaccination in more countries will promote global rabbit hemorrhagic disease vaccine market growth, especially in regions with large rabbit farming industries. Originating in the Netherlands during the 1940s, rabbit hemorrhagic disease was initially used to reduce domesticated rabbit populations. As the vaccine proves effective, it is now applied commercially. Certain untapped areas offer growth opportunities in the application of vaccines in commercial rabbit farming, wild rabbit populations, and underground pet systems.
- Broader use of vaccination in commercial rabbit farming: Vaccines have significant market penetration in commercial sectors. Countries like China, Europe, and the U.S. have large rabbit farming industries prone to outbreaks. Government and private vaccination drives can protect livestock and prevent economic losses, creating demand for vaccines.
- Nationalized oral and injectable vaccination programs: Widespread government-funded vaccination campaigns in Europe and Asia aim to achieve herd immunity and prevent outbreaks. These initiatives also influence farmers' perceptions, encouraging adoption.
- Expanded vaccine availability in emerging markets: Regions like Southeast Asia, Africa, and Latin America are emerging markets for rabbit hemorrhagic disease vaccines. Growing rabbit farming industries and local production, supported by government intervention, will improve access and demand.
- Vaccines with more than one strain: Developing multi-strain vaccines against strains like V1 and V2 offers strong market potential. The increasing prevalence of V2, a more lethal strain, drives the development of advanced vaccines, appealing to both commercial and private sectors.
- Vaccination of wild rabbit populations: Targeting wild rabbits, which can act as reservoirs, is a new frontier. Vaccinating wild populations could help curb disease spread, although this application is still developing.
Strategic growth opportunities are driven by government support, expanding rabbit farming in underdeveloped countries, and the advent of multi-strain vaccines. These factors will enable manufacturers to increase production and outreach across different sectors and geographies.
Rabbit Hemorrhagic Disease Vaccine Market Driver and Challenges
The global rabbit hemorrhagic disease vaccine market is influenced by technological, economic, and regulatory factors. While efforts to improve vaccine accessibility and efficacy are ongoing, challenges such as high regulations and limited purchasing power in developing economies persist.
The market drivers include:
1. New product development in vaccine formulations: Advances in vaccine technology, including multi-strain vaccines, enhance market attractiveness by providing broader protection and longer-lasting immunity.
2. Growing interest in rabbit hemorrhagic disease infection and its economic impact: Rising incidence and awareness among farmers, veterinarians, and government stakeholders increase the demand for vaccines to reduce outbreaks and economic losses.
3. Support and regulation by governments: Legislative measures and funding support promote vaccine adoption, especially in Europe and Asia.
4. Development of the global rabbit farming industry: Growth in rabbit farming in underdeveloped regions creates new demand for vaccines.
5. Biosecurity and disease control measures: Rigor in disease prevention strategies, including vaccination, sustains market demand.
Challenges include:
1. Barriers to vaccine development meeting global standards: Lengthy approval processes in regions like the USA, Europe, and Japan can hinder market entry.
2. Intellectual property considerations: Patent laws and regional restrictions complicate manufacturing and export.
3. Evolving strains and vaccine resistance: Continuous mutation of the virus necessitates ongoing R&D and vaccine updates, which can reduce long-term effectiveness.
The market features technological improvements and strategic focus by companies, governments, and farmers. Addressing challenges such as regulation, virus mutation, and market access will unlock further opportunities, especially in emerging markets.
List of Rabbit Hemorrhagic Disease Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rabbit hemorrhagic disease vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rabbit hemorrhagic disease vaccine companies profiled in this report include-
- Mevak
- Qilu Animal Health Products Factory
- Romvac
- Riemser Arzneimittel AG
- Hipra
- Veterinary Serum and Vaccine Research Institute
- Bioveta
- Cavac
- State Research Institution
- Laboratorios Ovejero
Rabbit Hemorrhagic Disease Vaccine Market by Segment
The study includes a forecast for the global market by type, application, and region.
Rabbit Hemorrhagic Disease Vaccine Market by Type [Value from 2019 to 2031]:
- Inactivated Vaccines
- Live Attenuated Vaccines
- Subunit Vaccines
- DNA Vaccines
Rabbit Hemorrhagic Disease Vaccine Market by Application [Value from 2019 to 2031]:
- Veterinary Clinics
- Research Institutions
- Animal Farms
- Pharmaceutical Companies
Rabbit Hemorrhagic Disease Vaccine Market by Region [Value from 2019 to 2031]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Rabbit Hemorrhagic Disease Vaccine Market
The rabbit hemorrhagic disease vaccine market has significant economic impacts, as such diseases can be quite detrimental to rabbit farming businesses. Recent developments in the United States include the development of newer and more advanced vaccine formulations, growing awareness of the disease, and tighter government regulations on outbreaks. The United States, China, Germany, India, and Japan are all countries with large rabbit populations involved in the development and distribution of anti-BRD vaccines.
- United States: Higher instances of rabbit hemorrhagic disease have led to increased vaccine demand, primarily for rabbit hemorrhagic disease V2, which is gaining approval. Outbreaks, especially among wild rabbits, have prompted vaccine improvements and distribution efforts to reach smaller breeders and pet owners.
- China: Anti-rabbit hemorrhagic disease V2 vaccines were quickly adopted after outbreaks in several provinces, as China is a leading producer and supplier of rabbits for meat and fur. Vaccines for V2 have been produced rapidly, with vaccination programs incorporated into biosecurity policies.
- Germany: With a developed rabbit farming industry, Germany proactively manages outbreaks with strict biosecurity measures. Vaccines are an integral part of herd management, and safety standards are high to ensure consumer confidence.
- India: Rabbit hemorrhagic disease is emerging with the growth of the sector. The government and veterinary organizations are promoting awareness and vaccination, with imports from major players like China and Europe, and local production expected to follow.
- Japan: The domestic rabbit farming sector is growing, and the government recommends vaccine use. Vaccination campaigns targeting wild and domesticated rabbits have been successful, with collaborations with foreign manufacturers to develop affordable vaccines.
Features of the Global Rabbit Hemorrhagic Disease Vaccine Market
Market size estimates are provided in terms of value ($B).
Trend and forecast analysis covers 2019 to 2024 and 2025 to 2031, by segments and regions.
Segmentation analysis includes market size by type, application, and region in dollar value.
Regional analysis breaks down the market by North America, Europe, Asia Pacific, and Rest of the World.
Growth opportunities are identified across different types, applications, and regions.
Strategic analysis includes M&A, new product development, and competitive landscape.
Analysis of industry competitiveness is based on Porter's Five Forces model.
This report answers the following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the rabbit hemorrhagic disease vaccine market by type (inactivated vaccines, live attenuated vaccines, subunit vaccines, and DNA vaccines), application (veterinary clinics, research institutions, animal farms, and pharmaceutical companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
- 2.1 Background and Classifications
- 2.2 Supply Chain
3. Market Trends & Forecast Analysis
- 3.1 Macroeconomic Trends and Forecasts
- 3.2 Industry Drivers and Challenges
- 3.3 PESTLE Analysis
- 3.4 Patent Analysis
- 3.5 Regulatory Environment
4. Global Rabbit Hemorrhagic Disease Vaccine Market by Type
- 4.1 Overview
- 4.2 Attractiveness Analysis by Type
- 4.3 Inactivated Vaccines: Trends and Forecast (2019-2031)
- 4.4 Live Attenuated Vaccines: Trends and Forecast (2019-2031)
- 4.5 Subunit Vaccines: Trends and Forecast (2019-2031)
- 4.6 DNA Vaccines: Trends and Forecast (2019-2031)
5. Global Rabbit Hemorrhagic Disease Vaccine Market by Application
- 5.1 Overview
- 5.2 Attractiveness Analysis by Application
- 5.3 Veterinary Clinics: Trends and Forecast (2019-2031)
- 5.4 Research Institutions: Trends and Forecast (2019-2031)
- 5.5 Animal Farms: Trends and Forecast (2019-2031)
- 5.6 Pharmaceutical Companies: Trends and Forecast (2019-2031)
6. Regional Analysis
- 6.1 Overview
- 6.2 Global Rabbit Hemorrhagic Disease Vaccine Market by Region
7. North American Rabbit Hemorrhagic Disease Vaccine Market
- 7.1 Overview
- 7.2 North American Rabbit Hemorrhagic Disease Vaccine Market by Type
- 7.3 North American Rabbit Hemorrhagic Disease Vaccine Market by Application
- 7.4 United States Rabbit Hemorrhagic Disease Vaccine Market
- 7.5 Mexican Rabbit Hemorrhagic Disease Vaccine Market
- 7.6 Canadian Rabbit Hemorrhagic Disease Vaccine Market
8. European Rabbit Hemorrhagic Disease Vaccine Market
- 8.1 Overview
- 8.2 European Rabbit Hemorrhagic Disease Vaccine Market by Type
- 8.3 European Rabbit Hemorrhagic Disease Vaccine Market by Application
- 8.4 German Rabbit Hemorrhagic Disease Vaccine Market
- 8.5 French Rabbit Hemorrhagic Disease Vaccine Market
- 8.6 Spanish Rabbit Hemorrhagic Disease Vaccine Market
- 8.7 Italian Rabbit Hemorrhagic Disease Vaccine Market
- 8.8 United Kingdom Rabbit Hemorrhagic Disease Vaccine Market
9. APAC Rabbit Hemorrhagic Disease Vaccine Market
- 9.1 Overview
- 9.2 APAC Rabbit Hemorrhagic Disease Vaccine Market by Type
- 9.3 APAC Rabbit Hemorrhagic Disease Vaccine Market by Application
- 9.4 Japanese Rabbit Hemorrhagic Disease Vaccine Market
- 9.5 Indian Rabbit Hemorrhagic Disease Vaccine Market
- 9.6 Chinese Rabbit Hemorrhagic Disease Vaccine Market
- 9.7 South Korean Rabbit Hemorrhagic Disease Vaccine Market
- 9.8 Indonesian Rabbit Hemorrhagic Disease Vaccine Market
10. ROW Rabbit Hemorrhagic Disease Vaccine Market
- 10.1 Overview
- 10.2 ROW Rabbit Hemorrhagic Disease Vaccine Market by Type
- 10.3 ROW Rabbit Hemorrhagic Disease Vaccine Market by Application
- 10.4 Middle Eastern Rabbit Hemorrhagic Disease Vaccine Market
- 10.5 South American Rabbit Hemorrhagic Disease Vaccine Market
- 10.6 African Rabbit Hemorrhagic Disease Vaccine Market
11. Competitor Analysis
- 11.1 Product Portfolio Analysis
- 11.2 Operational Integration
- 11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
- 11.4 Market Share Analysis
12. Opportunities & Strategic Analysis
- 12.1 Value Chain Analysis
- 12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
- 12.3 Emerging Trends in the Global Rabbit Hemorrhagic Disease Vaccine Market
- 12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures
13. Company Profiles of the Leading Players Across the Value Chain
- 13.1 Competitive Analysis
- 13.2 Mevak
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.3 Qilu Animal Health Products Factory
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.4 Romvac
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.5 Riemser Arzneimittel AG
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.6 Hipra
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.7 Veterinary Serum and Vaccine Research Institute
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.8 Bioveta
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.9 Cavac
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.10 State Research Institution
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.11 Laboratorios Ovejero
- Company Overview
- Rabbit Hemorrhagic Disease Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14. Appendix
- 14.1 List of Figures
- 14.2 List of Tables
- 14.3 Research Methodology
- 14.4 Disclaimer
- 14.5 Copyright
- 14.6 Abbreviations and Technical Units
- 14.7 About Us
- 14.8 Contact Us
List of Figures
- Figure 1.1: Trends and Forecast for the Global Rabbit Hemorrhagic Disease Vaccine Market
- Figure 2.1: Usage of Rabbit Hemorrhagic Disease Vaccine Market
- Figure 2.2: Classification of the Global Rabbit Hemorrhagic Disease Vaccine Market
- Figure 2.3: Supply Chain of the Global Rabbit Hemorrhagic Disease Vaccine Market
- Figure 2.4: Driver and Challenges of the Rabbit Hemorrhagic Disease Vaccine Market
- Figure 3.1: Trends of the Global GDP Growth Rate
- Figure 3.2: Trends of the Global Population Growth Rate
- Figure 3.3: Trends of the Global Inflation Rate
- Figure 3.4: Trends of the Global Unemployment Rate
- Figure 3.5: Trends of the Regional GDP Growth Rate
- Figure 3.6: Trends of the Regional Population Growth Rate
- Figure 3.7: Trends of the Regional Inflation Rate
- Figure 3.8: Trends of the Regional Unemployment Rate
- Figure 3.9: Trends of Regional Per Capita Income
- Figure 3.10: Forecast for the Global GDP Growth Rate
- Figure 3.11: Forecast for the Global Population Growth Rate
- Figure 3.12: Forecast for the Global Inflation Rate
- Figure 3.13: Forecast for the Global Unemployment Rate
- Figure 3.14: Forecast for the Regional GDP Growth Rate
- Figure 3.15: Forecast for the Regional Population Growth Rate
- Figure 3.16: Forecast for the Regional Inflation Rate
- Figure 3.17: Forecast for the Regional Unemployment Rate
- Figure 3.18: Forecast for Regional Per Capita Income
- Figure 4.1: Global Rabbit Hemorrhagic Disease Vaccine Market by Type in 2019, 2024, and 2031
- Figure 4.2: Trends of the Global Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type
- Figure 4.3: Forecast for the Global Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type
- Figure 4.4: Trends and Forecast for Inactivated Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 4.5: Trends and Forecast for Live Attenuated Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 4.6: Trends and Forecast for Subunit Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 4.7: Trends and Forecast for DNA Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 5.1: Global Rabbit Hemorrhagic Disease Vaccine Market by Application in 2019, 2024, and 2031
- Figure 5.2: Trends of the Global Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application
- Figure 5.3: Forecast for the Global Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application
- Figure 5.4: Trends and Forecast for Veterinary Clinics in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 5.5: Trends and Forecast for Research Institutions in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 5.6: Trends and Forecast for Animal Farms in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 5.7: Trends and Forecast for Pharmaceutical Companies in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 6.1: Trends of the Global Rabbit Hemorrhagic Disease Vaccine Market ($B) by Region (2019-2024)
- Figure 6.2: Forecast for the Global Rabbit Hemorrhagic Disease Vaccine Market ($B) by Region (2025-2031)
- Figure 7.1: Trends and Forecast for the North American Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 7.2: North American Rabbit Hemorrhagic Disease Vaccine Market by Type in 2019, 2024, and 2031
- Figure 7.3: Trends of the North American Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2019-2024)
- Figure 7.4: Forecast for the North American Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2025-2031)
- Figure 7.5: North American Rabbit Hemorrhagic Disease Vaccine Market by Application in 2019, 2024, and 2031
- Figure 7.6: Trends of the North American Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2019-2024)
- Figure 7.7: Forecast for the North American Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2025-2031)
- Figure 7.8: Trends and Forecast for the United States Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 7.9: Trends and Forecast for the Mexican Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 7.10: Trends and Forecast for the Canadian Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 8.1: Trends and Forecast for the European Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 8.2: European Rabbit Hemorrhagic Disease Vaccine Market by Type in 2019, 2024, and 2031
- Figure 8.3: Trends of the European Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2019-2024)
- Figure 8.4: Forecast for the European Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2025-2031)
- Figure 8.5: European Rabbit Hemorrhagic Disease Vaccine Market by Application in 2019, 2024, and 2031
- Figure 8.6: Trends of the European Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2019-2024)
- Figure 8.7: Forecast for the European Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2025-2031)
- Figure 8.8: Trends and Forecast for the German Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 8.9: Trends and Forecast for the French Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 8.10: Trends and Forecast for the Spanish Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 8.11: Trends and Forecast for the Italian Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 8.12: Trends and Forecast for the United Kingdom Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 9.1: Trends and Forecast for the APAC Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 9.2: APAC Rabbit Hemorrhagic Disease Vaccine Market by Type in 2019, 2024, and 2031
- Figure 9.3: Trends of the APAC Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2019-2024)
- Figure 9.4: Forecast for the APAC Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2025-2031)
- Figure 9.5: APAC Rabbit Hemorrhagic Disease Vaccine Market by Application in 2019, 2024, and 2031
- Figure 9.6: Trends of the APAC Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2019-2024)
- Figure 9.7: Forecast for the APAC Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2025-2031)
- Figure 9.8: Trends and Forecast for the Japanese Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 9.9: Trends and Forecast for the Indian Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 9.10: Trends and Forecast for the Chinese Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 9.11: Trends and Forecast for the South Korean Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 9.12: Trends and Forecast for the Indonesian Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 10.1: Trends and Forecast for the ROW Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Figure 10.2: ROW Rabbit Hemorrhagic Disease Vaccine Market by Type in 2019, 2024, and 2031
- Figure 10.3: Trends of the ROW Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2019-2024)
- Figure 10.4: Forecast for the ROW Rabbit Hemorrhagic Disease Vaccine Market ($B) by Type (2025-2031)
- Figure 10.5: ROW Rabbit Hemorrhagic Disease Vaccine Market by Application in 2019, 2024, and 2031
- Figure 10.6: Trends of the ROW Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2019-2024)
- Figure 10.7: Forecast for the ROW Rabbit Hemorrhagic Disease Vaccine Market ($B) by Application (2025-2031)
- Figure 10.8: Trends and Forecast for the Middle Eastern Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 10.9: Trends and Forecast for the South American Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 10.10: Trends and Forecast for the African Rabbit Hemorrhagic Disease Vaccine Market ($B) (2019-2031)
- Figure 11.1: Porter's Five Forces Analysis of the Global Rabbit Hemorrhagic Disease Vaccine Market
- Figure 11.2: Market Share (%) of Top Players in the Global Rabbit Hemorrhagic Disease Vaccine Market (2024)
- Figure 12.1: Growth Opportunities for the Global Rabbit Hemorrhagic Disease Vaccine Market by Type
- Figure 12.2: Growth Opportunities for the Global Rabbit Hemorrhagic Disease Vaccine Market by Application
- Figure 12.3: Growth Opportunities for the Global Rabbit Hemorrhagic Disease Vaccine Market by Region
- Figure 12.4: Emerging Trends in the Global Rabbit Hemorrhagic Disease Vaccine Market
List of Tables
- Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Rabbit Hemorrhagic Disease Vaccine Market by Type and Application
- Table 1.2: Attractiveness Analysis for the Rabbit Hemorrhagic Disease Vaccine Market by Region
- Table 1.3: Global Rabbit Hemorrhagic Disease Vaccine Market Parameters and Attributes
- Table 3.1: Trends of the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 3.2: Forecast for the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 4.1: Attractiveness Analysis for the Global Rabbit Hemorrhagic Disease Vaccine Market by Type
- Table 4.2: Market Size and CAGR of Various Type in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 4.3: Market Size and CAGR of Various Type in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 4.4: Trends of Inactivated Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 4.5: Forecast for Inactivated Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 4.6: Trends of Live Attenuated Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 4.7: Forecast for Live Attenuated Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 4.8: Trends of Subunit Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 4.9: Forecast for Subunit Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 4.10: Trends of DNA Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 4.11: Forecast for DNA Vaccines in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 5.1: Attractiveness Analysis for the Global Rabbit Hemorrhagic Disease Vaccine Market by Application
- Table 5.2: Market Size and CAGR of Various Application in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 5.3: Market Size and CAGR of Various Application in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 5.4: Trends of Veterinary Clinics in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 5.5: Forecast for Veterinary Clinics in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 5.6: Trends of Research Institutions in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 5.7: Forecast for Research Institutions in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 5.8: Trends of Animal Farms in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 5.9: Forecast for Animal Farms in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 5.10: Trends of Pharmaceutical Companies in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 5.11: Forecast for Pharmaceutical Companies in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 6.1: Market Size and CAGR of Various Regions in the Global Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 6.2: Market Size and CAGR of Various Regions in the Global Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 7.1: Trends of the North American Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 7.2: Forecast for the North American Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 7.3: Market Size and CAGR of Various Type in the North American Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 7.4: Market Size and CAGR of Various Type in the North American Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 7.5: Market Size and CAGR of Various Application in the North American Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 7.6: Market Size and CAGR of Various Application in the North American Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 7.7: Trends and Forecast for the United States Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 7.8: Trends and Forecast for the Mexican Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 7.9: Trends and Forecast for the Canadian Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 8.1: Trends of the European Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 8.2: Forecast for the European Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 8.3: Market Size and CAGR of Various Type in the European Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 8.4: Market Size and CAGR of Various Type in the European Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 8.5: Market Size and CAGR of Various Application in the European Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 8.6: Market Size and CAGR of Various Application in the European Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 8.7: Trends and Forecast for the German Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 8.8: Trends and Forecast for the French Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 8.9: Trends and Forecast for the Spanish Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 8.10: Trends and Forecast for the Italian Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 8.11: Trends and Forecast for the United Kingdom Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 9.1: Trends of the APAC Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 9.2: Forecast for the APAC Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 9.3: Market Size and CAGR of Various Type in the APAC Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 9.4: Market Size and CAGR of Various Type in the APAC Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 9.5: Market Size and CAGR of Various Application in the APAC Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 9.6: Market Size and CAGR of Various Application in the APAC Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 9.7: Trends and Forecast for the Japanese Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 9.8: Trends and Forecast for the Indian Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 9.9: Trends and Forecast for the Chinese Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 9.10: Trends and Forecast for the South Korean Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 9.11: Trends and Forecast for the Indonesian Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 10.1: Trends of the ROW Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 10.2: Forecast for the ROW Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 10.3: Market Size and CAGR of Various Type in the ROW Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 10.4: Market Size and CAGR of Various Type in the ROW Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 10.5: Market Size and CAGR of Various Application in the ROW Rabbit Hemorrhagic Disease Vaccine Market (2019-2024)
- Table 10.6: Market Size and CAGR of Various Application in the ROW Rabbit Hemorrhagic Disease Vaccine Market (2025-2031)
- Table 10.7: Trends and Forecast for the Middle Eastern Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 10.8: Trends and Forecast for the South American Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 10.9: Trends and Forecast for the African Rabbit Hemorrhagic Disease Vaccine Market (2019-2031)
- Table 11.1: Product Mapping of Rabbit Hemorrhagic Disease Vaccine Suppliers Based on Segments
- Table 11.2: Operational Integration of Rabbit Hemorrhagic Disease Vaccine Manufacturers
- Table 11.3: Rankings of Suppliers Based on Rabbit Hemorrhagic Disease Vaccine Revenue
- Table 12.1: New Product Launches by Major Rabbit Hemorrhagic Disease Vaccine Producers (2019-2024)
- Table 12.2: Certification Acquired by Major Competitor in the Global Rabbit Hemorrhagic Disease Vaccine Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.